journal article·2019-02

Comparison and evaluation of in vitro degradation behaviors of organosilicone-modified gelatin hybrids

Zetian Zhang, Xiaona Han, Weining Du, Zhengjun Li, Lixin Li

Publisher page

Abstract

Degradation behavior is one of the most important characteristics of biomedical materials for their applications. Herein, we systematically investigate the in vitro degradation behaviors of γ-glycidoxypropyltrimethoxysilane (GT) and/or epoxy-terminated polydimethylsiloxane oligomer (ES)-modified gelatin hybrid materials in physiological conditions. Their microscopic appearance, chemical composition, thermal performance, and mechanical properties at different degradation periods were thoroughly characterized by a series of measurements. It was found that the degradation behavior of silica–gelatin hybrids could be modulated by controlling the proportion of GT to ES oligomers. In particular, ES/GT-G hybrid as a result of combination of ES and GT, exhibited a faster degradation rate than that of GT-G hybrid when using merely GT, and showed a more homogeneous degradation behavior during the degradation process. Additionally, these silica–gelatin hybrids showed low cytotoxicity to human renal epithelial cells, and the cell viability was all above 83%. This work is helpful for a further insight into the in vivo degradation of silica–gelatin hybrid scaffolds, which are promising in biomedical applications.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Collagen: Extraction and Characterization · Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (31)

Show source-provided references
1. Artzi N, Oliva N, Puron C, Shitreet S, Artzi S, Ramos AB, Groothuis A, Sahagian G, Edelman ER (2011) Nat Mater 10(9):704–70910.1038/nmat3095 ↗
2. Parenteaubareil R, Gauvin R, Berthod F (2010) Materials 3(3):1863–188710.3390/ma3031863 ↗
3. Ferreira AM, Gentile P, Chiono V, Ciardelli G (2012) Acta Biomater 8(9):3191–320010.1016/j.actbio.2012.06.014 ↗
4. Depan D, Shah JS, Misra RDK (2013) Polym Degrad Stab 98(11):2331–233910.1016/j.polymdegradstab.2013.08.007 ↗
5. Zhuang H, Zheng JP, Gao H, Yao KD (2007) J Mater Sci Mater Med 18(5):951–95710.1007/s10856-006-0093-y ↗
6. Zulkifli FH, Hussain FSJ, Yusoff MM (2014) Polym Degrad Stab 110(110):473–48110.1016/j.polymdegradstab.2014.10.017 ↗
7. Su K, Wang C (2015) Biotechnol Lett 37(11):2139–214510.1007/s10529-015-1907-0 ↗
8. Gómez-Guillén MC, Giménez B, López-Caballero ME, Montero MP (2011) Food Hydrocolloid 25(8):1813–182710.1016/j.foodhyd.2011.02.007 ↗
9. Goncalves S, Chiossone-Kerdel JA, Bianco AS, Ercolino JM, Hernandez-Rojas J (2015) Acta Otolaryngol 135(1):14–2510.3109/00016489.2014.951455 ↗
10. Zheng R, Duan H, Xue J, Liu Y, Feng B, Zhao S, Zhu Y, Liu Y, He AJ, Zhang WJ, Zhou GD (2014) Biomaterials 35(1):152–16410.1016/j.biomaterials.2013.09.082 ↗
11. Lei B, Shin KH, Koh YH, Kim HE (2014) J Biomed Mater Res B 102(7):1528–153610.1002/jbm.b.33133 ↗
12. Rutnakornpituk M, Ngamdee P, Phinyocheep P (2006) Carbohydr Polym 63(2):229–23710.1016/j.carbpol.2005.08.063 ↗
13. Xue Y, Wang L, Shao Y, Jin Y, Chen X, Lei B (2014) Chem Eng J 251(251):158–16410.1016/j.cej.2014.04.049 ↗
14. Kaali P, Momcilovic D, Markström A, Aune R, Czel G, Karlsson S (2010) J Appl Polym Sci 115(2):802–81010.1002/app.31119 ↗
15. Rhee SH, Choi JY, Kim HM (2002) Biomaterials 23(24):4915–492110.1016/S0142-9612(02)00251-X ↗
16. Tonda-Turo C, Gentile P, Saracino S, Chiono V, Nandagiri VK, Muzio G, Canuto RA, Ciardelli G (2011) Int J Biol Macromol 49(4):700–70610.1016/j.ijbiomac.2011.07.002 ↗
17. Han X, Du W, Li Y, Li Z, Li L (2016) J Appl Polym Sci 133(8) https://doi.org/10.1002/APP.4305910.1002/APP.43059 ↗
18. Lei B, Shin KH, Noh DY, Jo IH, Koh YH, Choi WY, Kim HE (2012) J Mater Chem 22(28):14133–1414010.1039/c2jm31290e ↗
19. Mahony O, Tsigkou O, Ionescu C, Minelli C, Ling L, Hanly R, Smith ME, Stevens MM, Jones JR (2010) Adv Funct Mater 20(22):3835–384510.1002/adfm.201000838 ↗
20. Huang Y, Onyeri S, Siewe M, Moshfeghian A, Madihally SV (2005) Biomaterials 26(36):7616–762710.1016/j.biomaterials.2005.05.036 ↗
21. Australia S (2009) Biological evaluation of medical devices-part 5: tests for in vitro cytotoxicity. International Organization for Standardization: Geneva, Switzerland
22. Mosmann TJ (1983) Immunol Methods 65(1-2):55–6310.1016/0022-1759(83)90303-4 ↗
23. Sisson K, Zhang C, Farachcarson MC, Chase DB, Rabolt JF (2009) Biomacromolecules 10(7):1675–168010.1021/bm900036s ↗
24. Du WN, Han XN, Li ZJ, Li YP, Li, LX, Wang, KY (2015) J Appl Polym Sci 132(44) https://doi.org/10.1002/APP.42727 .10.1002/APP.42727 ↗
25. Wojciechowska P, Pietras P, Maciejewski H (2015) Adv Polym Tech 33:36–38
26. Du WN, Dai GC, Wang BC, Li ZJ, Li LX (2018) J Appl Polym Sci 135(20) https://doi.org/10.1002/app.46264 .10.1002/app.46264 ↗
27. Ning CQ, Mehta J, Elghannam A (2005) J Mater Sci 16(4):355–360
28. Komsa-Penkova R, Koynova R, Kostov G, Tenchov BG (1996) Biochim Biophys Acta 1297(2):171–18110.1016/S0167-4838(96)00092-1 ↗
29. Neshati Z, Bahrami AR, Eshtiaghhosseini H, Matin MM, Housaindokht MR, Tabari T, Edalatmanesh MA (2012) Cytotechnology 64(5):485–49510.1007/s10616-012-9426-5 ↗
30. Galia CR, Macedo CA, Rosito R, Mello TMD, Moreira LF (2008) Clinics 63(6):801–80610.1590/S1807-59322008000600016 ↗
31. Bayraktar O, Malay O, Ozgarip Y, Batigã NA (2005) Eur J Pharm Biopharm 60(3):373–38110.1016/j.ejpb.2005.02.002 ↗